State Street’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.57M Sell
566,205
-19,853
-3% -$188K ﹤0.01% 2965
2026
Q1
$5.02M Buy
586,058
+48,669
+9% +$437K ﹤0.01% 2965
2025
Q4
$4.75M Buy
537,389
+44,030
+9% +$509K ﹤0.01% 3020
2025
Q3
$6.54M Buy
493,359
+88,958
+22% +$1.11M ﹤0.01% 2875
2025
Q2
$5.52M Buy
404,401
+117,638
+41% +$1.58M ﹤0.01% 2897
2025
Q1
$3.94M Buy
286,763
+79,649
+38% +$1.16M ﹤0.01% 2971
2024
Q4
$3.54M Buy
207,114
+99,554
+93% +$1.73M ﹤0.01% 3104
2024
Q3
$1.98M Buy
+107,560
New +$1.9M ﹤0.01% 3333

Other funds holding ARDT

State Street's ARDT Position: Q2 2026 in Review

State Street reduced its Ardent Health (ARDT) stake by 3.4% in Q2 2026, selling an estimated $188K and leaving 566,205 shares worth $5.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2965.

State Street first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.54M in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • State Street held 566,205 shares of Ardent Health worth $5.57M as of Q2 2026.
  • State Street sold 19,853 Ardent Health shares in Q2 2026, an estimated $188K.
  • Ardent Health made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2965 holding.
  • State Street first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • State Street's Ardent Health position peaked at $6.54M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.